Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Meredith Clement to HIV Infections

This is a "connection" page, showing publications Meredith Clement has written about HIV Infections.

 
Connection Strength
 
 
 
5.331
 
  1. Irie WC, Corneli A, Perry B, Kelsey C, Bickham J, Davenport T, Naresh A, Holman S, Clement M. Start the Conversation: Development of a Training Program to Build OB/GYN Resident Capacity for PrEP Prescribing in Routine Care. J Int Assoc Provid AIDS Care. 2026 Jan-Dec; 25:23259582261488339.
    View in: PubMed
    Score: 0.322
  2. Clement ME, Thomas J, Kelsey C, Jagneaux T, O'Neal C, Lim S, Widman S, Marcus J, Okeke NL, Wilson S. HEalth Record Optimization for Identifying Candidates for HIV PRe-Exposure Prophylaxis: A Community-Informed Approach to Model Development. AIDS Patient Care STDS. 2025 07; 39(7):266-272.
    View in: PubMed
    Score: 0.296
  3. Clement ME, Perry B, McKenna K, Beckford J, Davenport T, Murray E, Magee V, Bickham JN, Siren J, Smith A, Lillis R, Corneli A. Identifying Implementation Strategies to Enhance HIV Pre-Exposure Prophylaxis Uptake Among Black Cisgender Women in New Orleans, Louisiana. AIDS Patient Care STDS. 2024 03; 38(3):144-150.
    View in: PubMed
    Score: 0.270
  4. Lovett A, Luder R, Lillis RA, Butler I, Siren J, Gomez S, Kamis K, Obafemi O, Rowan SE, Baral S, Clement ME. Client Perspectives on the Development of a Rapid PrEP Initiative at a Sexual Health Center in New Orleans, Louisiana. J Int Assoc Provid AIDS Care. 2024 Jan-Dec; 23:23259582241258559.
    View in: PubMed
    Score: 0.267
  5. Clement ME, Beckford J, Lovett A, Siren J, Adorno M, Legrand S, Bennett M, Taylor J, Hanlen-Rosado E, Perry B, Corneli A. Sexually Transmitted Infection Prevention Perspectives in Black Men Who Have Sex With Men Taking Preexposure Prophylaxis in New Orleans. Sex Transm Dis. 2024 02 01; 51(2):90-95.
    View in: PubMed
    Score: 0.266
  6. Essajee NM, Oddo-Moise H, Hagensee ME, Lillis RA, Maffei J, Butler I, Lovett A, Sokol T, Clement ME. Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak. AIDS Res Hum Retroviruses. 2023 11; 39(11):587-592.
    View in: PubMed
    Score: 0.260
  7. Burns CM, Pung L, Witt D, Gao M, Sendak M, Balu S, Krakower D, Marcus JL, Okeke NL, Clement ME. Development of a Human Immunodeficiency Virus Risk Prediction Model Using Electronic Health Record Data From an Academic Health System in the Southern United States. Clin Infect Dis. 2023 01 13; 76(2):299-306.
    View in: PubMed
    Score: 0.250
  8. Corneli A, Perry B, Taylor J, Beckford J, Molokwu N, Reif S, Wilson J, Gulden C, Bickham J, Siren J, Thompson W, Clement ME. HIV Prevention During the COVID-19 Pandemic: Sexual Activity and PrEP Use Among Black Same-Gender-Loving Men and Black Cisgender Women. AIDS Educ Prev. 2022 04; 34(2):142-157.
    View in: PubMed
    Score: 0.237
  9. Lillis R, Beckford J, Fegley J, Siren J, Hinton B, Gomez S, Taylor SN, Butler I, Halperin J, Clement ME. Evaluation of an HIV Pre-Exposure Prophylaxis Referral System: From Sexual Health Center to Federally Qualified Health Center Pre-Exposure Prophylaxis Clinic. AIDS Patient Care STDS. 2021 09; 35(9):354-359.
    View in: PubMed
    Score: 0.227
  10. Eaton EF, Clement ME. Wave the Yellow Flag: Why We Should Prioritize Routine Human Immunodeficiency Virus and Sexually Transmitted Infection Care Now. J Infect Dis. 2021 03 29; 223(6):930-932.
    View in: PubMed
    Score: 0.221
  11. Clement ME, Nicchitta M, Sun Y, Ellis A, Chakraborty H, McGee K, Eagle C, Frye J, Taylor D, Okeke NL, Johnston B, Seña AC, McKellar M. Preexposure Prophylaxis Outcomes in an Urban Community in North Carolina: Discontinuation of Care and Sexually Transmitted Infections. Sex Transm Dis. 2021 03 01; 48(3):183-188.
    View in: PubMed
    Score: 0.220
  12. Schwartz J, Grimm J, Zimmerman R, Clement M. Information Seeking and MSM's Beliefs about PrEP and Condoms. Health Commun. 2022 06; 37(7):889-896.
    View in: PubMed
    Score: 0.218
  13. Clement ME, Kofron R, Landovitz RJ. Long-acting injectable cabotegravir for the prevention of HIV infection. Curr Opin HIV AIDS. 2020 01; 15(1):19-26.
    View in: PubMed
    Score: 0.203
  14. Clement ME, Johnston BE, Eagle C, Taylor D, Rosengren AL, Goldstein BA, Seña AC. Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States. AIDS Patient Care STDS. 2019 08; 33(8):366-371.
    View in: PubMed
    Score: 0.195
  15. Clement ME, Okeke NL, Munn T, Hunter M, Alexis K, Corneli A, Seña AC, McGee K, McKellar MS. Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care. J Acquir Immune Defic Syndr. 2018 02 01; 77(2):e25-e27.
    View in: PubMed
    Score: 0.177
  16. Clement ME, Lin L, Navar AM, Okeke NL, Naggie S, Douglas PS. Lower likelihood of cardiac procedures after acute coronary syndrome in patients with human immunodeficiency virus/acquired immunodeficiency syndrome. Medicine (Baltimore). 2018 Feb; 97(6):e9849.
    View in: PubMed
    Score: 0.177
  17. Clement ME, Seidelman J, Wu J, Alexis K, McGee K, Okeke NL, Samsa G, McKellar M. An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S. AIDS Care. 2018 05; 30(5):650-655.
    View in: PubMed
    Score: 0.173
  18. Clement ME, Park LP, Navar AM, Okeke NL, Pencina MJ, Douglas PS, Naggie S. Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study. Clin Infect Dis. 2016 08 01; 63(3):407-13.
    View in: PubMed
    Score: 0.157
  19. Clement ME, Okeke NL, Hicks CB. Fever and Rash in a Patient With Hepatitis. JAMA. 2015 Jul 28; 314(4):400-1.
    View in: PubMed
    Score: 0.149
  20. Landovitz RJ, Fogel JM, Gao F, Hanscom B, Piwowar-Manning E, Moser A, Marzinke MA, Cyktor J, Seisa M, Halvas EK, Kofron R, Jennings A, Clement M, Tran HV, Gaur A, Fichtenbaum CJ, Asmelash A, Soto-Torres L, Rooney JF, Rinehart AR, Cohen MS, Grinsztejn B, Eshleman SH. Prospective HIV RNA Screening With Long-acting Cabotegravir Pre-exposure Prophylaxis in HPTN 083. Clin Infect Dis. 2026 Oct 28; 83(4):e787-e794.
    View in: PubMed
    Score: 0.081
  21. Hazra A, Chan PA, Clement M, Kaperak CJ, Safa H, Havens JP, Springer SA, Blumenthal J, Spinelli M, Doblecki-Lewis S, Multani A, Gipson J, Cherabie J, Vail R, Sukumaran S, Cannon CA, Lillis R, Butler I, Turner C, Taraschi E, Narcisse-Cempini G, Kunzmann L, Smith R, Halbur D, Patel RR. Real-World Implementation Outcomes of Lenacapavir for HIV Preexposure Prophylaxis: Early Findings From a Multicenter United States Cohort. Clin Infect Dis. 2026 Oct 28; 83(4):596-600.
    View in: PubMed
    Score: 0.081
  22. Ong I, Brin M, Michaels CL, Hripcsak M, Casimir T, Brown ZE, Monger M, Drake M, Schwiesow J, Wynne T, Yates DB, Jackson S, Turner K, Clement ME, Kelsey C, Lelutiu-Weinberger CT, Hai AH, Batey DS, Schnall R. Multilevel factors influencing HIV care and management in the Deep South: insights from HIV care professionals. AIDS Care. 2026 Oct; 38(10):2322-2337.
    View in: PubMed
    Score: 0.080
  23. Moeser MJ, Council OD, Long N, Kincer L, Dennis AM, Eron J, Wohl D, Farel CE, Dittmer DP, Pluta L, Nelson J, Mohammadi A, Etemad B, Li JZ, McGann H, Smit E, Clement M, Yau T, Menezes P, Bowman NM, Zhou S, Joseph SB. A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage. J Infect Dis. 2026 Jun 16; 233(6):1005-1014.
    View in: PubMed
    Score: 0.079
  24. Llibre JM, Iniesta C, Tittle V, Clement M, Rivero Á, Armenteros-Yeguas I, Álvarez-López P, Ryan P, Arribas JR, Moreno S. Closing the PrEP access gap in Europe: a strategic framework for equity and innovation among difficult-to-reach populations. J Antimicrob Chemother. 2026 Feb 02; 81(3).
    View in: PubMed
    Score: 0.077
  25. Irie WC, Nicol MR, Clement M, Bukusi EA, Bekker LG, Molina JM, Stewart J. Event-driven PrEP beyond cisgender men who have sex with men. Lancet HIV. 2025 Feb; 12(2):e143-e153.
    View in: PubMed
    Score: 0.072
  26. Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, Brinson C, Brites C, Cahn P, Cantos VD, Clark J, Clement M, Creticos C, Crofoot G, Diaz RS, Doblecki-Lewis S, Gallardo-Cartagena JA, Gaur A, Grinsztejn B, Hassler S, Hinojosa JC, Hodge T, Kaplan R, Lacerda M, LaMarca A, Losso MH, Valdez Madruga J, Mayer KH, Mills A, Mounzer K, Ndlovu N, Novak RM, Perez Rios A, Phanuphak N, Ramgopal M, Ruane PJ, Sánchez J, Santos B, Schine P, Schreibman T, Spencer LY, Van Gerwen OT, Vasconcelos R, Vasquez JG, Zwane Z, Cox S, Deaton C, Ebrahimi R, Wong P, Singh R, Brown LB, Carter CC, Das M, Baeten JM, Ogbuagu O. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. N Engl J Med. 2025 Apr 03; 392(13):1261-1276.
    View in: PubMed
    Score: 0.071
  27. Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, Spinelli MA, Kofron RM, Berman R, Piwowar-Manning EM, Richardson PA, Sullivan PA, Lucas JP, Anderson PL, Hendrix CW, Adeyeye A, Rooney JF, Rinehart AR, Cohen MS, McCauley M, Grinsztejn B. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV. 2023 12; 10(12):e767-e778.
    View in: PubMed
    Score: 0.066
  28. Neilan AM, Landovitz RJ, Le MH, Grinsztejn B, Freedberg KA, McCauley M, Wattananimitgul N, Cohen MS, Ciaranello AL, Clement ME, Reddy KP, Hyle EP, Paltiel AD, Walensky RP. Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis. Ann Intern Med. 2022 04; 175(4):479-489.
    View in: PubMed
    Score: 0.059
  29. Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, Kallas EG, Kelley CF, Losso MH, Madruga JV, Middelkoop K, Phanuphak N, Santos B, Sued O, Valencia Huamaní J, Overton ET, Swaminathan S, Del Rio C, Gulick RM, Richardson P, Sullivan P, Piwowar-Manning E, Marzinke M, Hendrix C, Li M, Wang Z, Marrazzo J, Daar E, Asmelash A, Brown TT, Anderson P, Eshleman SH, Bryan M, Blanchette C, Lucas J, Psaros C, Safren S, Sugarman J, Scott H, Eron JJ, Fields SD, Sista ND, Gomez-Feliciano K, Jennings A, Kofron RM, Holtz TH, Shin K, Rooney JF, Smith KY, Spreen W, Margolis D, Rinehart A, Adeyeye A, Cohen MS, McCauley M, Grinsztejn B. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med. 2021 08 12; 385(7):595-608.
    View in: PubMed
    Score: 0.057
  30. Alenezi F, Bloomfield GS, Okeke NL, Velagapudi P, Abudaqa L, Ijioma N, Dunning A, Alajmi H, Clement ME, Shah SH, Naggie S, Velazquez EJ. Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency Virus. Am J Cardiol. 2019 09 15; 124(6):966-971.
    View in: PubMed
    Score: 0.049
  31. Okeke NL, Alenezi F, Bloomfield GS, Dunning A, Clement ME, Shah SH, Naggie S, Velazquez EJ. Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort. J Card Fail. 2018 Aug; 24(8):496-503.
    View in: PubMed
    Score: 0.046
  32. Clement ME, Collins LF, Wilder JM, Mugavero M, Barker T, Naggie S. Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure. Infect Dis Clin North Am. 2018 06; 32(2):407-423.
    View in: PubMed
    Score: 0.045
  33. Paul DW, Neely NB, Clement M, Riley I, Al-Hegelan M, Phelan M, Kraft M, Murdoch DM, Lucas J, Bartlett J, McKellar M, Que LG. Development and validation of an electronic medical record (EMR)-based computed phenotype of HIV-1 infection. J Am Med Inform Assoc. 2018 02 01; 25(2):150-157.
    View in: PubMed
    Score: 0.044
  34. Okeke NL, Craig DM, Muehlbauer MJ, Ilkayeva O, Clement ME, Naggie S, Shah SH. Metabolites predict cardiovascular disease events in persons living with HIV: a pilot case-control study. Metabolomics. 2018 03; 14(3).
    View in: PubMed
    Score: 0.044
  35. Clifton DC, Clement ME, Holland TL, Cox GM, Dicks KV, Stout JE. Suboptimal HIV Testing Among Patients Admitted With Pneumonia: A Missed Opportunity. AIDS Educ Prev. 2017 08; 29(4):377-388.
    View in: PubMed
    Score: 0.043
  36. Okeke NL, Chin T, Clement M, Chow SC, Hicks CB. Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis. AIDS Care. 2016; 28(4):475-82.
    View in: PubMed
    Score: 0.038
  37. Naggie S, Clement M, Lusk S, Osinusi A, Himmel T, Lucas JE, Thompson WJ, Dubois L, Moseley MA, Clark PJ, Kottilil S, Patel K. Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations. Proteomics Clin Appl. 2019 05; 13(3):e1800006.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)